Status:
COMPLETED
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
Lead Sponsor:
Temple University
Collaborating Sponsors:
Pennsylvania Department of Health
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-80 years
Brief Summary
The overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for chronic obstructive pulm...
Detailed Description
* Overall objective: To determine why African American and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for COPD-and to show that repea...
Eligibility Criteria
Inclusion
- Phase 1 \& Gene Expression: --Current hospitalization for COPD exacerbation
- Phase 1 \& 2: COPD \& ONE of the following criteria:
- History of hospitalization for COPD exacerbation, OR
- Currently on supplemental oxygen, OR
- History of evaluation for lung transplant or LVRS, OR
- \>/= 6 months post-LVRS
- Phase 1 or 2:
- Current or former smoker, \>/= 20 pack-yr. smoking history
- FEV1 \</= 70%; FEV1/FVC \</= 70%
- Life expectancy of \> 6 months
Exclusion
- \< 20 pack-yr. smoking history
- Diagnosis of pulmonary fibrosis, bronchiectasis, mediastinal mass, or presence of a pulmonary mass
- Asthma
- FEV1 \> 70% or FEV1/FVC \>70%
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
1066 Patients enrolled
Trial Details
Trial ID
NCT00774176
Start Date
June 1 2004
End Date
May 1 2008
Last Update
June 29 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Lancaster General Hospital
Lancaster, Pennsylvania, United States, 17604
2
Temple University School of Medicine
Philadelphia, Pennsylvania, United States, 19140
3
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, United States, 15224